Literature DB >> 17691326

Behavioural and physiological effects of electrical stimulation in the nucleus accumbens: a review.

K van Kuyck1, L Gabriëls, P Cosyns, L Arckens, V Sturm, S Rasmussen, B Nuttin.   

Abstract

Electrical stimulation (ES) in the brain is becoming a new treatment option in patients with treatment-resistant obsessive-compulsive disorder (OCD). A possible brain target might be the nucleus accumbens (NACC). This review aims to summarise the behavioural and physiological effects of ES in the NACC in humans and in animals and to discuss these findings with regard to neuroanatomical, electrophysiological and behavioural insights. The results clearly demonstrate that ES in the NACC has an effect on reward, activity, fight-or-flight, exploratory behaviour and food intake, with evidence for only moderate physiological effects. Seizures were rarely observed. Finally, the results of ES studies in patients with treatment-resistant OCD and in animal models for OCD are promising.

Entities:  

Mesh:

Year:  2007        PMID: 17691326     DOI: 10.1007/978-3-211-33081-4_43

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  18 in total

Review 1.  PET/MRI for neurologic applications.

Authors:  Ciprian Catana; Alexander Drzezga; Wolf-Dieter Heiss; Bruce R Rosen
Journal:  J Nucl Med       Date:  2012-11-09       Impact factor: 10.057

2.  Anatomy of the human nucleus accumbens: a combined morphometric study.

Authors:  Ioannis Mavridis; Efstathios Boviatsis; Sophia Anagnostopoulou
Journal:  Surg Radiol Anat       Date:  2011-01-04       Impact factor: 1.246

3.  Invasive and Non-invasive Neurostimulation for OCD.

Authors:  Isidoor O Bergfeld; Eva Dijkstra; Ilse Graat; Pelle de Koning; Bastijn J G van den Boom; Tara Arbab; Nienke Vulink; Damiaan Denys; Ingo Willuhn; Roel J T Mocking
Journal:  Curr Top Behav Neurosci       Date:  2021

4.  Wireless Instantaneous Neurotransmitter Concentration System: electrochemical monitoring of serotonin using fast-scan cyclic voltammetry--a proof-of-principle study.

Authors:  Christoph J Griessenauer; Su-Youne Chang; Susannah J Tye; Christopher J Kimble; Kevin E Bennet; Paul A Garris; Kendall H Lee
Journal:  J Neurosurg       Date:  2010-09       Impact factor: 5.115

5.  Deep-brain stimulation of the nucleus accumbens in obsessive compulsive disorder: clinical, surgical and electrophysiological considerations in two consecutive patients.

Authors:  Angelo Franzini; Giuseppe Messina; Orsola Gambini; Riccardo Muffatti; Silvio Scarone; Roberto Cordella; Giovanni Broggi
Journal:  Neurol Sci       Date:  2010-02-03       Impact factor: 3.307

6.  Role of social encounter-induced activation of prefrontal serotonergic systems in the abnormal behaviors of isolation-reared mice.

Authors:  Yukio Ago; Ryota Araki; Tatsunori Tanaka; Asuka Sasaga; Saki Nishiyama; Kazuhiro Takuma; Toshio Matsuda
Journal:  Neuropsychopharmacology       Date:  2013-02-20       Impact factor: 7.853

Review 7.  Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia.

Authors:  Kjell Fuxe; Daniel Marcellino; Amina S Woods; Leo Giuseppina; Tiziana Antonelli; Luca Ferraro; Sergio Tanganelli; Luigi F Agnati
Journal:  J Neural Transm (Vienna)       Date:  2009-01-21       Impact factor: 3.575

8.  Radiofrequency Lesioning for Movement and Psychiatric Disorders-Experience of 107 Cases.

Authors:  Paresh K Doshi
Journal:  Front Hum Neurosci       Date:  2021-06-14       Impact factor: 3.169

9.  Subregion-Specific Modulation of Excitatory Input and Dopaminergic Output in the Striatum by Tonically Activated Glycine and GABA(A) Receptors.

Authors:  Louise Adermark; Rhona B C Clarke; Mia Ericson; Bo Söderpalm
Journal:  Front Syst Neurosci       Date:  2011-10-18

10.  Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety- and depression-like behavior.

Authors:  Claudia Schmuckermair; Stefano Gaburro; Anupam Sah; Rainer Landgraf; Simone B Sartori; Nicolas Singewald
Journal:  Neuropsychopharmacology       Date:  2013-01-16       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.